These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite]. Schulz W; Wendt T; Scherer D; Kober G Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236 [TBL] [Abstract][Full Text] [Related]
3. The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1. Sobolski J; Vandermoten P; Stoupel E; Berkenboom G; Degre S Am Heart J; 1985 Mar; 109(3 Pt 2):700-3. PubMed ID: 3838407 [TBL] [Abstract][Full Text] [Related]
4. Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine. Schulz W; Kober G; Bernauer R; Kaltenbach M Am Heart J; 1985 Mar; 109(3 Pt 2):694-9. PubMed ID: 3838406 [TBL] [Abstract][Full Text] [Related]
7. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration]. Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899 [No Abstract] [Full Text] [Related]
8. [Anti-ischemic effects of SIN-1, a molsidomine metabolite, during coronary angioplasty and antiplatelet effects in humans]. Darius H; Erbel E; Schmucker B; Reusch U; Meyer J Presse Med; 1988 May; 17(20):1033-6. PubMed ID: 2969099 [TBL] [Abstract][Full Text] [Related]
9. [Effects of intracoronary injection of SIN-1 on vasoconstriction of epicardial arteries induced by acetylcholine]. Dubois-Randé JL; Adnot S; Dupouy P; Castaigne A; Geschwind H Arch Mal Coeur Vaiss; 1993 Jun; 86(6):881-7. PubMed ID: 8274060 [TBL] [Abstract][Full Text] [Related]
10. Coronary vasodilatory action after nicorandil: a quantitative angiographic study. Suryapranata H; Serruys PW Am J Cardiol; 1989 Jun; 63(21):80J-85J. PubMed ID: 2525332 [TBL] [Abstract][Full Text] [Related]
11. [Acute and chronic effects of molsidomine in therapeutic coronary angioplasty]. Darius H; Erbel R; Rupprecht HJ; Pop T; Meyer J Med Klin (Munich); 1990 Feb; 85 Suppl 1():23-6. PubMed ID: 2185404 [TBL] [Abstract][Full Text] [Related]
12. How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions? Jost S; Nolte CW; Sturm M; Hausleiter J; Hausmann D Int J Card Imaging; 1998 Dec; 14(6):357-72. PubMed ID: 10453390 [TBL] [Abstract][Full Text] [Related]
16. Standardization of coronary vasomotor tone with intracoronary nitroglycerin. Jost S; Sturm M; Hausmann D; Lippolt P; Lichtlen PR Am J Cardiol; 1996 Jul; 78(1):120-3. PubMed ID: 8712104 [TBL] [Abstract][Full Text] [Related]
17. [Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease]. Münzel T; Kurz S; Heitzer T; Luhmann C; Just H Med Klin (Munich); 1994 Jul; 89 Suppl 2():38-41. PubMed ID: 7968900 [No Abstract] [Full Text] [Related]
18. [SIN-1 in intracoronary administration]. Schulz W Presse Med; 1988 May; 17(20):1027-32. PubMed ID: 2969098 [TBL] [Abstract][Full Text] [Related]
19. [Hemodynamic response to intracoronary injection of a vasodilator during coronary angiography. A randomized comparative study of trinitrin and linsidomin ]. Chevalier B; Lancelin B Arch Mal Coeur Vaiss; 1991 Sep; 84(9):1345-51. PubMed ID: 1958119 [TBL] [Abstract][Full Text] [Related]
20. Coronary vasodilation with nitrocompounds--is there a maximum? Jost S; Reil G; Knop I; Rafflenbeul W; Auricchio A; Frombach R; Gulba D; Hecker H; Lichtlen P Z Kardiol; 1989; 78 Suppl 2():38-40; discussion 64-7. PubMed ID: 2511691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]